There may be no other industry as prone to hit-or-miss investments as biotechnology. An astounding 90% of drugs that enter phase 1 clinical trials never reach commercialization, and that means failure is far more common than success. As a result, many biotech companies research a slate of drugs in hopes of having at least one pan out. That’s not the […]
View gallery.Biotech is big, and the industry has been big for quite some time.As a matter of fact, biotechnology has been the second-best performing industry over the last two years.Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.However, at the end of the day, the big […]
Read More Why stocks ‘more vulnerable’ in 2015: PaulsenIt might be tempting to try something new altogether, but Sam Stovall of S&P Capital IQ says in a report that one of the best sectors of 2014 is looking good again. The health-care sector has jumped more than 23% during 2014 — making it one of the best places for stocks.And […]
After neglecting my writing for some time the New Year is as good as any to begin the practice gain. Upon reviewing 2014 I’ve decided to drop a few things from my tool box while replacing them with some fresher ideas that I’ve been working on. The first wrench that I plan to use more frequently is using sectors through […]
View gallery.After last week’s hammering of biotech stocks, many have not been able to recover to hit new highs with the overall market.Previous high flyers such as Agios Pharmaceuticals Inc (NASDAQ: AGIO) and Receptos Inc (NASDAQ: RCPT) have bounced, but still lag the Nasdaq.Others, such as Bluebird Bio Inc (NASDAQ: BLUE) have actually managed to eek out new highs.Unfortunately, there are the […]
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year.If your portfolio could use some exposure to healthcare and biotechs, join the Fool’s Michael Douglass and Todd Campbell, along with special guest Kristine Harjes, to learn more about three promising stocks in the […]
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
How Consolidated Water Stands Out In A Strong Industry
Investors Failed To Catch Breitburn Energy Partners, Did You?
See original:
Biotech Stocks Make Big Moves In Final Days Of 2014 … – Benzinga
[…]
by Jim Walker on Friday, December 26th, 2014 | Comments OffChristmas has come and gone and it is time to look for end of the year stock bargains. Fundamental analysis of stocks is always the key to picking up bargain stocks but where do you look and what are the important factors that will drive stock prices? Here are few […]
Biotech stocks to buy in 2015: Biotech was one of the most profitable sectors this year. Through Dec. 18, the S&P 500 Biotechnology Index is up 43.6% in 2014, and the Nasdaq Biotechnology Index is up 36.9%.Those gains are three to six times as big as the broader markets’. In 2014 through Dec. 18, the Dow Jones Industrial Average is […]
It’s been an eventful and promising year for pharma. The eyeforpharma team choose their top five pharma news stories of 2014.Globally, healthcare is high on citizens’ and policy-makers’ agendas and, wherever healthcare and business intersect, we find controversy. Indeed, this year, pharma has hardly seemed to be out of the headlines, becoming part of the international news agenda on several […]
